• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

后上型巨大肩袖撕裂修复术预后影响因素的临床与影像学研究

Clinical and imaging study on prognostic factors influencing the repair of posterior supremal giant rotator cuff tear

摘要:

目的:探讨使用后上四联征(posterosuperior tetralogy,PS-Tetra)评分预测后上型巨大肩袖撕裂修复术预后的可行性。方法:回顾性纳入2016年2月至2020年6月于北京积水潭医院运动医学科接受关节镜下修复巨大后上型肩袖撕裂的患者95例,男48例、女47例,年龄(58.52±8.33)岁(范围27~76岁);83例完全修复、12例部分修复。使用美国肩肘外科协会(American Shoulder & Elbow Surgeons,ASES)评分与肩关节活动度评估肩关节功能。行MR检查评估术前肩袖脂肪浸润、萎缩、改良Patte分级、PS-Tetra评分与术后肌腱完整性,并比较不同PS-Tetra评分组(0~2分、3~4分)的肩关节功能差异。采用二分类logistic回归分析筛选后上型巨大肩袖撕裂不可修复及术后再撕裂的危险因素。结果:83例完全修复的患者中17例(20%)出现再撕裂。PS-Tetra评分0~2分组术后ASES评分增高[术后(58.52±8.33)分和术前(47.30±17.40)分, t=-19.642, P<0.001]、前屈上举增加(术后157.60°±3.85°和术前116.88°±50.89°, t=-7.272, P<0.001)、外旋增加(术后45.26°±14.69°和术前37.34°±18.65°, t=-4.043, P<0.001)及内旋增加[术后L 1(T 7-臀部)和术前L 2(T 7-臀部), Z=-2.737, P=0.006],差异均有统计学意义;PS-Tetra评分3~4分组仅术后ASES评分较术前改善[术后(69.17±15.91)分和术前(46.85±20.73)分, t=-11.167, P=0.001],肩关节活动度的差异无统计学意义。改良Patte分级Ⅲ级[ OR=26.827,95% CI(2.089,344.500), P=0.012]是不可修复的危险因素。主力侧[ OR=9.407, 95% CI(1.044,84.784), P=0.046]与PS-Tetra评分3~4分[ OR=5.037,95% CI(1.028,26.623), P=0.046]是再撕裂的危险因素。 结论:对后上型巨大肩袖撕裂修复而言,术前PS-Tetra评分≥3分是术后肩关节功能恢复不佳与术后再撕裂的危险因素。

更多
abstracts:

Objective:To assess the feasibility of using the posterosuperior tetralogy (PS-Tetra) score for predicting the prognosis of repair of posterosuperior massive rotator cuff tears.Methods:Data were retrospectively reviewed for patients who underwent repair of posterosuperior massive rotator cuff tears from February 2016 to June 2020. A total of 95 (male 48, female 47) shoulders with an average age of 58.52±8.33 years (range, 27-76 years) were included. The American Shoulder and Elbow Surgeons (ASES) scores and shoulder range of motions (ROM) were used to evaluate shoulder function. MRI was used to assess preoperative fatty infiltration (FI), atrophy, modified Patte's classification, PS-Tetra score and postoperative tendon integrity. The shoulder function was compared between groups of different PS-Tetra scores. The binary logistic regression was used to determine the risk factors of irreparability and retear.Results:83 cases of repair of posterosuperior massive rotator cuff tears were finally included. Complete repairs were performed in 83 cases, and partial repairs were performed in 12 cases. Retear was observed in 17 (20%) cases. The ASES scores (postoperative 58.52±8.33 vs. preoperative 47.30±17.40, t=-19.642, P<0.001), ROM of forward flexion (postoperative 157.60°±13.85° vs. preoperative 116.88°±50.89°, t=-7.272, P<0.001), external rotation (postoperative 45.26°±14.69° vs. preoperative 37.34°±18.65°, t=-4.043, P<0.001) and internal rotation [postoperative L 1 (T 7-buttock) vs. preoperative L 2 (T 7-buttock), Z=-2.737, P=0.006] were significantly improved postoperatively in the group with PS-Tetra score between 0 and 2. In the group with PS-Tetra score of 3 and 4, the ASES scores (postoperative 69.17±15.91 vs. preoperative 46.85±20.73, t=-11.167, P=0.001) were significantly improved postoperatively, while the ROMs were not. Modified Patte stageⅢ[ OR=26.827, 95% CI (2.089, 344.500), P=0.012] was the risk factor of irreparability. Dominant side involvement [ OR=9.407, 95% CI (1.044, 84.784), P=0.046) and PS-Tetra score of 3 and 4 [ OR=5.037, 95% CI (1.028, 26.623), P=0.046] were risk factors of retear. Conclusions:For repair of posterosuperior massive rotator cuff tears, preoperative PS-Tetra score of 3 and 4 was the risk factors of poor postoperative shoulder functions and retear.

More
作者: 郭斯翊 [1] 朱以明 [1] 鲁谊 [1] 张璞 [1] 郑峒 [1] 覃其煌 [1] 姜春岩 [1]
期刊: 《中华骨科杂志》2024年44卷14期 979-986页 ISTICPKUCSCD
栏目名称: 临床论著
DOI: 10.3760/cma.j.cn121113-20240124-00056
发布时间: 2024-09-03
基金项目:
国家自然科学基金项目 National Natural Science Foundation of China
  • 浏览:0
  • 下载:0

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学网小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学网小程序

使用
帮助
Alternate Text
调查问卷
Baidu
map